We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+6.45%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.59%
AUM
$469M
AUM Growth
+$33.4M
Cap. Flow
+$8.52M
Cap. Flow %
1.82%
Top 10 Hldgs %
34.39%
Holding
143
New
6
Increased
16
Reduced
46
Closed
6

Top Sells

Rank Stock Value
1
MET icon
MetLife
MET
+$9.78M
2
HSY icon
Hershey
HSY
+$6.45M
3
CIEN icon
Ciena
CIEN
+$5.73M
4
BWA icon
BorgWarner
BWA
+$3.66M
5
VTRS icon
Viatris
VTRS
+$2.62M

Sector Composition

Rank Sector Weight
1 Healthcare 19.22%
2 Technology 16.43%
3 Consumer Discretionary 13.34%
4 Financials 11.15%
5 Industrials 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.43T
$24.5M 5.22%
1,054,592
-140
-0% -$2.98K
GOOG icon
2
Alphabet (Google) Class C
GOOG
$4.51T
$18M 3.83%
621,662
-582
-0.1% -$15.8K
DIS icon
3
Walt Disney
DIS
$169B
$15.7M 3.34%
182,540
-325
-0.2% -$26.5K
INTC icon
4
Intel
INTC
$492B
$15.3M 3.26%
494,606
+17,800
+4% +$488K
VTRS icon
5
Viatris
VTRS
$20.4B
$15.1M 3.22%
292,535
-53,400
-15% -$2.62M
HIG icon
6
Hartford Financial Services
HIG
$38.6B
$15.1M 3.21%
420,330
-1,700
-0.4% -$59.8K
ELV icon
7
Elevance Health
ELV
$82B
$14.9M 3.18%
138,785
-15,950
-10% -$1.64M
CELG
8
DELISTED
Celgene Corp
CELG
$14.5M 3.1%
169,148
+8,000
+5% +$608K
JNJ icon
9
Johnson & Johnson
JNJ
$605B
$14.2M 3.03%
135,688
+32,200
+31% +$3.25M
PEP icon
10
PepsiCo
PEP
$188B
$14.1M 3.01%
158,060
-550
-0.3% -$47.5K
BWA icon
11
BorgWarner
BWA
$12.8B
$13.9M 2.96%
241,877
-66,558
-22% -$3.66M
HXL icon
12
Hexcel
HXL
$7.79B
$13.9M 2.95%
338,675
-16,950
-5% -$705K
SDRL
13
DELISTED
Seadrill Limited Common Stock
SDRL
$13.4M 2.85%
1,251
+141
+13% +$1.38M
DHI icon
14
D.R. Horton
DHI
$41.1B
$13.2M 2.82%
537,545
+14,225
+3% +$325K
ROP icon
15
Roper Technologies
ROP
$38.5B
$13.1M 2.8%
89,880
+28,000
+45% +$3.91M
CVX icon
16
Chevron
CVX
$372B
$12.3M 2.63%
94,376
+32,125
+52% +$4M
AJG icon
17
Arthur J. Gallagher & Co
AJG
$62.2B
$12.1M 2.59%
260,570
-13,775
-5% -$628K
KBH icon
18
KB Home
KBH
$3.47B
$12.1M 2.58%
+648,130
New +$10.9M
EMBJ
19
Embraer S.A. ADS
EMBJ
$12.8B
$12M 2.56%
329,700
+14,500
+5% +$512K
THC icon
20
Tenet Healthcare
THC
$19.8B
$11.9M 2.54%
253,600
+12,450
+5% +$563K
COST icon
21
Costco
COST
$417B
$11.8M 2.52%
102,655
-1,845
-2% -$212K
SLB icon
22
SLB Ltd
SLB
$73.3B
$11.7M 2.5%
99,310
+2,625
+3% +$271K
ESRX
23
DELISTED
Express Scripts Holding Company
ESRX
$10.9M 2.32%
157,195
-19,425
-11% -$1.37M
COF icon
24
Capital One
COF
$135B
$10.9M 2.32%
131,515
UNP icon
25
Union Pacific
UNP
$172B
$10.6M 2.26%
106,488
-14,620
-12% -$1.42M

Similar funds

Kelly Lawrence W & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Kelly Lawrence W & Associates held 143 positions worth $469M, up 7.7% from $436M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Kelly Lawrence W & Associates's Q2 2014 filing shows 6 new, 16 increased, 46 reduced and 6 closed positions. Its largest new stake was Bed Bath & Beyond Inc: 178,400 shares worth $10.2M. The largest sale was MetLife, an estimated $9.78M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Kelly Lawrence W & Associates's largest Q2 2014 buy was Bed Bath & Beyond Inc: 178,400 shares worth $10.2M.
  • Kelly Lawrence W & Associates added most to Mondelez International in Q2 2014, an estimated $4.8M increase.
  • Kelly Lawrence W & Associates's biggest Q2 2014 reduction was MetLife, cutting an estimated $9.78M.
  • Kelly Lawrence W & Associates fully exited Dentsply Sirona in Q2 2014, selling an estimated $684K.
  • Kelly Lawrence W & Associates's ten largest holdings make up 34% of its $469M portfolio in Q2 2014.
  • Kelly Lawrence W & Associates opened 6 new positions and closed 6 in Q2 2014.
  • Kelly Lawrence W & Associates's portfolio value rose 7.7% quarter-over-quarter to $469M.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2014, filed 15 Aug 2014.